Women with cancer detected by age group.
Nowadays, screening uses the method of X-ray mammography for the early diagnosis of breast cancer. However, as a screening method, X-ray mammography has its limitations, such as age, periodicity of screening, ‘dense’ mammary gland and dynamic survey (repeated radiation). In order to overpass these limitations, more advanced alternative methods of breast examination should be used, which would be as effective as the ‘golden standard.’ Characteristics of electroimpedance diagnostics are given. The aim of screening is to detect breast cancer including early breast cancer (tumor size below 1 cm) and to form a survey of high-risk group. In order to reach these aims, the following actions need to be undertaken: search for areas with anomalous conductivity, detection of distorted mammographic scheme and evaluation of age-related electrical conductivity. The application of a scale for age-related breast conductivity with defined percentile limits allows to organize a survey group. Electrical properties of a cancerous tumor differ significantly from those of the surrounding tissues. Statistics of anomalous conductivity in cases of breast cancer is given. The disease development connected with the destruction of epithelial basement membrane is linked with various phenomena occurring in the tumor and the surrounding tissues. Statistics of disrupted mammographic scheme in cases of cancer is given.
- electroimpedance mammography
- breast cancer
- survey group
- mammary gland structure
- age-related electrical conductivity
- anomalous conductivity
- distorted mammographic scheme
1. Introduction: problems of breast cancer screening
In 1968 James Maxwell Glover Wilson and Gunnar Jungner supported by the World Health Organization published a research named . In 1972 the American Cancer Society together with the National Cancer Institute developed the Breast Cancer Detection Demonstration Project, aimed to perform X-ray mammography breast cancer screening for more than quarter of a million of American women.
Since then, X-ray mammography has become not only the main screening method but also the ‘gold’ standard in diagnostics. It is important to distinguish the difference between screening tests and early diagnostics. Early diagnostics implies early detection of tumors in patients with symptoms. Screening test means early detection of tumors in patients without symptoms . Nowadays, screening uses X-ray mammography as the method of early diagnostics of breast cancer. However, used as a screening method, X-ray mammography has its limitations and drawbacks. We’ll name some problems of the main screening method.
Sensitivity of X-ray mammography used for breast cancer diagnostics above 80%, which would satisfy screening requirements, is observed only in the 70–79, 80–89 and 90+ age groups.
These data show the necessity to implement additional effective screening programs for young women including screening with the application of alternative technology in order to lengthen the preclinical detection stage, which would lead to the decrease of breast cancer mortality rate . In order to overcome the existing limitations, it is necessary to use modern alternative methods of breast examination that would be equal to the ‘gold’ standard in its effectiveness. Electrical impedance mammography is a diagnostic method satisfying the criteria set by the World Health Organization for screening for diseases. MEIK v.5.6, electrical impedance mammograph developed and manufactured by PKF ‘Sim-technika,’ Russia, uses advanced technologies of imaging and processing of electrical impedance images of breast. It is a noninvasive technology of image creation, it uses 3D-tomography system, it is a form of ‘soft-field’ tomography, it applies ‘non-local’ method of tomographic image creation and cross-sectional approach to data collection, it uses back-projection method as the algorithm of image reconstruction, and finally it allows to receive quantitative diagnostic information. The electrical properties of biological tissue as of colloid-dispersed system in an alternating electric field depend on the concentration and behavior of the chemical components of the tissue. The electric properties of a tumor differ significantly from those of the surrounding tissues. The aim of screening is to detect breast cancer including early breast cancer (tumor size below 1 cm) and to form a survey or high-risk group. In order to reach these aims, the following actions need to be undertaken: search for areas with abnormal conductivity, detection of distorted mammographic scheme and evaluation of age-related electrical conductivity.
2. Formation of survey group
|Definition||Electrical conductivity||Percentile limits|
|Amorphous structure||More than 0.66||>90‰|
|Mixed type with amorphous component prevailing||0.57–0.65||75–90‰|
|Mixed type with acinar-ductal component prevailing||0.22–0.29||10–25‰|
|Acinar-ductal type prevailing||Less than 0.22||<10‰|
Therefore, the electrical conductivity index can be used for the evaluation of breast structure from the point of view of electrical impedance mammography. It is a known fact that the structure of breast defines the breast density. For this reason, the defined ranges of electrical conductivity correspond to different types of ‘density’ of breast. Table 4 shows the structure of the breast according to the electrical impedance mammography and types of density according to American College of Radiology [ACR] classification. ‘Dense’ breast, i.e. the so-called acinar-ductal type, is characterized by low electrical conductivity index. High electrical conductivity index is common for amorphous type of breast [consisting mostly of adipose and connective tissue]. The image shows examples of electrical impedance mammograms of patients from different age groups with different structure of breast: a 25-year-old patient with acinar-ductal type (Figure 1) and extreme breast density and 63-year-old patient with amorphous structure and low breast density (Figure 2).
On the Figure 2 you can find examples of electrical impedance mammograms of the same age group but with different breast structure: 36-year-old patient with acinar-ductal type and high tissue density and 34-year-old patient with amorphous structure and low tissue density (Figure 2). In order to form a survey group, it is necessary to determine not only the breast structure but also the correspondence between the structure type and age-related electrical conductivity of the breast.
3. Early diagnostics of breast cancer
The electrical properties of cancer tumor differ greatly from the electrical properties of the surrounding tissues. It was established during several researches that malignant tumors have lower electrical impedance than normal tissues. The results of these studies are given in Table 6 .
|Authors, year||Frequency range investigated||Nature of study and results|
|Fricke et al. , 1926||20 kHz||They measured the parallel capacitance and resistance of the following excised samples from the breast—fat, gland, mastitis, fibroadenoma and carcinoma They found significantly higher permittivity of the tumor tissue at 20 kHz than the normal or benign tissues.|
|Singh et al. , 1979||100 Hz–100 kHz||They performed in vivo impedance measurements on female breasts with and without tumors. Their results showed that malignant tumors have higher relative permittivity and lower resistance than those of normal breast tissue|
|Chaudhary et al. , 1984||3 MHz–3 GHz||They examined excised normal and malignant breast tissues and found that the conductivity and permittivity of malignant tissues are higher than those of normal tissues, especially at frequencies lesser than 100 MHz.|
|Surowiec et al. , 1988||20 kHz–100 MHz||They conducted in vitro dielectric studies in three different samples of breast tissues—the main tumor tissue, the tissue immediately surrounding the tumor and the peripheral normal tissue. They found that the tumor tissues have a low-frequency (100 kHz) conductivity around 2–4 mS/cm which is higher than the conductivity of normal tissue (below 1 mS/cm) and lower than that of the tissue surrounding the tumor (8 mS/cm).|
|Morimoto et al. [33, 34], 1990||0–200 kHz||They measured the extracellular and intracellular resistances and membrane capacitance of breast tumors in vivo. They concluded that there are statistically significant differences between normal and cancerous tissues. However, it has been reported that malignant tumors have lowered capacitance compared to benign tumors. This is different from the results of the study conducted by Jossinet  and Fricke  which have recorded higher capacitance values for malignant tumors.|
|Jossinet , 1996||488 Hz–1 MHz||The study examined six groups of normal and pathological breast tissues in vitro. The variability of impedivity within each group was assessed by statistical methods. It was found that the variability was smaller in adipose tissue, carcinoma and fibroadenoma above 10 kHz.|
|Jossinet , 1998||488 Hz–1 MHz||Using the same data from , it was found that the cancerous tissue differed significantly from fibroadenoma and mammary gland tissues by the modulus of impedivity up to 31.25 kHz and from the remaining tissue groups (connective tissue, adipose tissue and mastopathy) by the low-frequency-limit resistivity and the phase angle from 125 kHz to 1 MHz. It was also observed that neither the impedivity nor the low-frequency-limit resistivity nor the fractional power value was different between the groups of normal and benign tissues.|
|Jossinet et al. , 1999||488 Hz–1 MHz||Again using the same excised data collected for previous studies, they defined a set of eight parameters that could differentiate cancerous breast tissues from noncancerous ones. They concluded that a combination of the parameters over various frequencies is necessary for the accurate differentiation among tissues.|
|Chauveau et al. , 1999||10 kHz–10 MHz||They conducted an in vitro study of normal and pathological breast tissues and observed significant differences in their dielectric properties. They have determined three indices based on extracellular resistance, intracellular resistance and membrane capacitance to differentiate between various tissue pathologies—normal, invasive ductal carcinoma (IDC), IDC with stromal reaction and fibrocystic changes.|
S. Haltiwanger published the results of several studies about the specific features of tumor cells that influence their electrical activity:
Cancer cells have cell membranes that exhibit different electrochemical properties and a different distribution of electrical charges than normal tissues .
Cancer cells also have different lipid and sterol content than normal cells .
Cancer cells have altered membrane composition and membrane permeability, which results in the movement of potassium, magnesium and calcium out of the cell and the accumulation of sodium and water into the cell .
The result of these mineral movements, membrane composition changes, energy abnormalities and membrane charge distribution abnormalities is a drop in the normal membrane potential and membrane capacitance.
An increase in the intracellular concentration of positively charged sodium ions and an increase in negative charges on the cell coat (glycocalyx) are two of the major factors causing cancerous cells to have lower membrane potential than healthy cells .
Two of the most outstanding electrical features of cancer cells are that they constantly maintain their membrane potential at a low value and their intracellular concentration of sodium at a high concentration [34, 35].
A sustained elevation of intracellular sodium may act as a mitotic trigger causing cells to go into cell division .
The results of the researches confirm that electrical conductivity is an appropriate parameter for the differentiation between healthy tissue and tumor tissue. The fundamental difference of electrical impedance scanning from other tomographic methods is that besides visual evaluation of the image, the electrical impedance mammography offers quantitative information . If the diagnostic method under discussion yields a quantitative result, a value is defined, the overpassing of which is deemed to be a sufficient cause for qualitative evaluation, i.e. the so-called differentiation point. It is essential to define a precise differentiation point. The point with electrical conductivity exceeding 3 standard deviations [std] is considered to be the point of differentiation between breast cancer patients and healthy people. The detection of areas with high electrical conductivity exceeding 3 std. outside the lactiferous sinus in electrical impedance mammograms, which differs greatly from the electrical conductivity of normal breast tissue, is used as a diagnostic criteria for the detection of breast cancer . Moreover, sizes of tumors as a rule do not exceed 10 mm.
Figure 3 shows the electrical impedance mammogram of a breast cancer patient with the following parameters: IC = 0.56, std. = 0.12. In the mammogram, at the 3 o’clock position near the areola, a focus without a sharp contour is visualized, its IC being equal to 0.94. Therefore, the IC in the area of interest exceeds the mammogram IC by more than 3 std.
Below X-ray images [fibroadipose involution, the upper external quadrant shows a mass less than 1 cm in size with uneven contour] and ultrasound mammograms [the external quadrant contains a lesion of irregular shape with uneven structure, 7 × 8 mm in size, with vascularization] of the same patient are presented.
For the last few years, clinical studies have been held in different countries determining the potential of electrical impedance mammography in breast cancer diagnostics. All these studies used electrical impedance computer mammograph MEIK v.5.6, abnormal electrical conductivity being the diagnostic criterion .
Sachin Prasad and colleagues performed a study to determine the diagnostic efficiency of 3D electrical impedance tomography [EIT] compared to mammography (mg) and ultrasonography (USG) in breast imaging . A group of 88 patients with various breast complaints was examined using combined mammography and ultrasonography [MG & USG] or either of these modalities alone. The same patients were then examined using the 3D EIT imaging system MEIK. The study revealed that there was no overall significant difference in sensitivity between MG-USG [p = 0.219] and MG-EIT [p = 0.779] and USG-EIT [p = 0.169].
O. Raneta and colleagues  performed a study to analyze the possibilities of electrical impedance tomography [EIT] application in the differential diagnosis of pathologic lesions of the breast either solely or in combination with MMG/USG . A group of 870 eligible women with suspected pathological breast lesion discovered by mammography [MMG] or ultrasound examination [USG] were recommended to pass histological examination to verify the diagnosis. The sensitivity of MMG increased from 87.8% when using it as an independent method to 94.5% with EIT added. The sensitivity of USG increased from 86.7% when used as an independent method to 93.3% with EIT added. The results of the study showed that the use of EIT in addition to MMG/USG can improve the sensitivity of these methods and increase the rate of early detection of breast cancer with minimal economic costs and time input of highly qualified staff.
Daglar and colleagues  performed a study to compare the usefulness of the breast electrical conductivity measures performed in a surgical examination room against conventional breast screening modalities for identifying the symptomatic lesions of the breast tissue . A group of 181 patients were examined with ultrasonography [USG], mammography [MG] and electrical impedance scanning [EIS] modalities, which were followed up for 24 months to clarify the lesion tumor progression relationship. EIS exhibited compatible sensitivity [81.2%], accuracy [84.6%] and PPV [81.8%] rates with USG in BI-RADS 4 subgroup, combination of these modalities raised sensitivity rates to 92.31%, accuracy and PPV to 100%. EIS results in BI-RADS 3 subgroup were pointed out 77.8% specificity and 87.5% NPV rates. Breast electrical impedance measures should be useful to reduce the number of the unnecessary follow-up and biopsy rates in the clinical setting.
Xu Feng and colleagues  performed a study to investigate the diagnostic accuracy of electrical impedance tomography [EIT] for benign and malignant breast diseases in comparison to conventional ultrasonography and mammography . A total of 121 patients with 126 breast lesions who underwent ultrasonography mammography and EIT were enrolled in the study. All of these lesions were confirmed by pathological biopsy. The accuracy, sensitivity, specificity, positive predictive value and negative predictive value of EIT, ultrasonography and mammography were calculated with histology used as the ‘gold’ standard. The accuracy of EIT, ultrasonography and mammography were 75.4, 81.7 and 76.1%, respectively. The sensitivity was 76.8, 94.6 and 74.4%, respectively. The specificity was 74.3, 71.4 and 77.6%, respectively. The accuracy, sensitivity and specificity of EIT combined with ultrasound in the diagnosis of breast lesions were 91.3, 98.2 and 85.7%, respectively. The accuracy [χ2 = 4.896, P = 0.027] and specificity [χ2 = 4.242, P = 0.039] were significantly higher on EIT than ultrasound. The accuracy, sensitivity and specificity of EIT combined with mammography were 95.5, 97.4 and 93.9%, respectively, which were significantly higher than those of mammography [χ2 = 13.474, P < 0.001; χ2 = 8.573, P = 0.003; χ2 = 5.333, P = 0.021]. Used together with ultrasound or mammography, the electrical impedance tomography could be a valuable complementary examination in the diagnosis of breast diseases. Furthermore, EIT could provide very useful additional information for metabolic assessment of mammary glands, which may be used for early screening of breast diseases.
Blanca Murillo-Ortiz and colleagues  performed a study to know the effectiveness of the electrical impedance mammography for the detection of mammary carcinoma in 615 women from 25 to 70 years of age . The sensitivity and specificity of the electrical impedance mammography (MEIK) was 85 and 97%, respectively.
Therefore, the studies showed high level of sensitivity and specificity, which allows to use abnormal electrical conductivity as the diagnostic criterion in screenings for early detection of breast cancer.
4. Distorted mammographic scheme in cases of breast cancer
Distortion of normal mammographic scheme appears in case of structural changes, such as pathological shadows and microcalcifications. These focal changes can be easily detected with the help of medical equipment checking the density of tissue. But along with focal changes, breast cancer can reveal itself through diffuse changes of breast structure, which also leads to the disruption of normal mammographic scheme, and this can be detected with electrical impedance mammography. For X-ray diagnostics, diffuse changes are a difficult matter since they do not change the density of breast tissue.
As the disease develops, which leads to the destruction of the basement membrane of the epithelium, the lesion and surrounding tissues may undergo various phenomena followed by changes of electrical properties of the tumor mass:
Edema and softening of fibrous connective tissue
Slimming, hyalinosis, calcification
Appearance of purulent areas
Lymphocytic infiltration of tissue
Therefore, tumor growth is naturally accompanied by the changes of electrical properties of tumor and surrounding tissues. The criteria of distortion of normal mammographic scheme in cases of breast cancer are changes of contour, anatomical changes, local changes of electrical conductivity and change of comparative electrical conductivity. As previously stated, the electrical impedance method gives a possibility of quantitative imaging . Quantitative analysis of an electrical impedance image allows to receive a histogram of electrical conductivity distribution and compares it with reference values. As a rule, distorted mammographic scheme in case of breast cancer is accompanied by changes of electrical conductivity of breast tissues. This phenomenon facilitates visual and quantitative interpretation of the lesion and can be used for diagnostic purposes. Figure 4 shows several variants of distorted mammographic scheme in cases of breast cancer and their visual evaluation [1, contour deformation; 2,4, thickening of contour; 3, anatomic distortion; 5,6, local changes].
For the classification of a patient (healthy or affected), test of differences in the form of distributions [λ criterion], i.e. Kolmogorov-Smirnov test in Dx modification, is used . This criterion, which is a nonparametric test, allows to determine the statistical value of differences in the distribution of any normal or abnormal features, including the distribution of electrical conductivity in electrical impedance tomograms. For the assessment of informativeness of distribution divergence, Kulback informativeness measure is applied . High informativeness of the detected differences allows to refer the patient with high degree of probability to one class or the other (e.g. norm or cancer). In case of breast cancer, histogram of affected breast gets displaced, and Dx criterion exceeds 40% (Figure 5).
Table 7 shows the comparative electrical conductivity data for patients with breast cancer, benign changes, for healthy patients and for those with different types of breast structure; the data was received during clinical studies in the hospitals of Russia. It is evident that divergence of histograms of electrical conductivity distribution by more than 40% is observed only in cases of breast cancer, and actually divergence of histograms of electrical conductivity distribution by more than 30% in the majority of cases is observed during oncological processes in the breast.
During the oncological process, natural changes of general and local electrical conductivity occur. And distortion of normal mammographic scheme may occur at an early stage of the disease. This is the reason why this criterion is included in the EIM scale of breast cancer diagnostics .
A scoring scale used for the evaluation of mass lesions in the breast by means of electrical impedance mammography allowed to relate the information received with BI-RADS ACR categorization (Table 8). The EIM scoring scale allowed to standardize the description of mass lesions examined by means of electrical impedance mammography and to use the patient follow-up algorithm developed by the American College of Radiology.
|Common scale||BI-RADS categories|
|No score||BI-RADS 0 poor image|
|0–1||BI-RADS 1 lesion is not defined|
|2–3||BI-RADS 2 benign tumors—routine mammography|
|4||BI-RADS 3 probably benign findings|
|5–7||BI-RADS 4 suspicious abnormality—biopsy|
|>8||BI-RADS 5 highly suggestive of malignancy—treatment/biopsy|
Therefore, the distortion of normal mammographic scheme along with abnormal electrical conductivity is one of the most frequent diagnostic indicators of breast cancer.
Sensitivity and specificity are operational characteristics that allow to evaluate the effectiveness of a diagnostic method. Operational characteristics are influenced by several factors: size and area of pathology, age of patients in the groups under study and prevalence in the group under study. In the process of sensitivity and specificity calculation, the disease prevalence in the group is not taken into account. It is a significant benefit since it gives a possibility to spread the data received in a group of people onto other groups, with different prevalence. However, it is also a drawback of evaluation. The diagnostic test data should be spread cautiously onto groups of people that differ significantly from the group under study.
The calculation method used for operational characteristics such as sensitivity and specificity has its own peculiarities in cases of low and high prevalence.
Characteristics of screenings:
Unrestricted population of sampling group, as a rule including many thousands of people
Significant prevailing of healthy patients over patients with pathologies
Impossibility to use reference method and histological verification of the diagnosis due to a large number of healthy patients
Significant prevailing of patients with early stages of disease from among the number of those with revealed pathologies
Impossibility to apply operational characteristics: specificity and sensitivity
Characteristics of a diagnostic study:
Restricted sampling population, several dozens of respondents
Significant prevailing of patients with pathologies over healthy ones
Significant prevailing of patients with progressing disease over those with early stages
Use of referential method and histological verification of diagnosis
Application of operational characteristics: sensitivity and specificity
Characteristics of a diagnostic study:
Unrestricted sampling population and timing
Prevailing of healthy patients over patients with pathologies
Full range of disease manifestation: from early-stage patients to patients with progressing disease
Use of referential method and histological verification of diagnosis
Application of operational characteristics: specificity and sensitivity
Is it correct to spread operational characteristics received from the second and third examples onto the screening?
Spreading the estimations received in high-prevalence conditions onto low-prevalence conditions should be done with caution. High-prevalence spectrum of disease manifestations differs from low-prevalence spectrum. Since diagnostic centers accumulate patients with a certain disease, in the structure of high-prevalence cases of progressing disease dominate significantly over early stages of disease.
Since every stage of disease has its own symptoms or specific criteria, for every stage the diagnostic criteria should have their own operational characteristics.
Operational characteristics are determined on the basis of restricted sample group of patients with verified diagnoses. Since reference tests, as a rule, are indifferent for the respondents, in such studies the number of persons not affected by the disease under study is minimal. In case of data spreading, it can influence the expected number of false-positive and false-negative results.
The optimal study for receiving operational characteristics of the method used from the point of view of patient selection, prevalence level, from the point of view of commonality of the methodology used and the usage of the reference method and histological verification is not a low-prevalence study, such as screening, and is not a high-prevalence study as inpatient examination but a study held in an imaging room for the prevalence typical for the settlement. Shifting of operational characteristics in the situation of medium prevalence is preferable since it has a well-balanced data set.
Electrical impedance mammography is a tool for primary breast cancer screening. It is confirmed by its high informativeness, safety for the staff and patient, portability and mobility. Operational characteristics (sensitivity and specificity) are determined on a restricted sample group, the so-called high- and medium-prevalence group, with the use of reference method (X-ray mammography) and verified diagnosis. The studies were held in oncological centers and clinics. The study on a group of patients with high and medium prevalence demonstrated high sensitivity and specificity of the electrical impedance mammography. The received operational characteristics can be spread onto groups of patients with low prevalence and be used during planning of screening studies. It allows to use the electrical impedance mammography for primary breast cancer screening of big groups of population with low prevalence. The electrical impedance mammography fulfills its functional screening tasks without ionizing radiation and other potentially hazardous means. It can be used to perform examinations for women of all age groups in outpatient departments, schools, clinics for women, maternity hospitals and sanatoriums, i.e. in the gathering places for women. In such a way, the problem of organization of mass screening for women can easily be solved.
Conflict of interest
The authors declare no conflict of interest.
Wilson JMG, Jungner G. Handbook Principles and Practice of Screening for Disease Dedicated to Screening of Diseases. World Health Organization; 1968
Barchuk AA, Belyaev AM, Filochkina AV, Arseniev AI. Cancer screening and mortality. Anssi Auvinen практическая онкология, Т. 2016; 17(4)
Gabriel, Domchek. Breast cancer in young women. Breast Cancer Research. 2010; 12:212
Berrington De González A, Reeves G. Mammographic screening before age 50 years in the UK: Comparison of the radiation risks with the mortality benefits. British Journal of Cancer. 2005; 93(5, 5):590-596
Breast Screening Programme, England. Statistics for 2004-15. Health & Social Care Information Centre. Published 24 February 2016
Britton P, Warwick J, Wallis MG, O’keeffe S, Taylor K, Sinnatamby R, et al. Measuring the accuracy of diagnostic imaging in symptomatic breast patients: Team and individual performance. The British Journal of Radiology. 2012; 85:415-422
Leung et al. Can breast magnetic resonance imaging demonstrate characteristic finding of preoperative ductal carcinoma in situ in Taiwanese woman? Asian Journal of Surgery. 2010; 33(3):143-149
Nagao Y, Kawaguchi Y, Sugiyama Y, Saji S, Kashiki Y. Relationship between mammographic density and the risk of breast cancer in Japanese women: A case-control study. Breast Cancer. 2003; 10(3):228-233
Boyd et al. Mammographic densities and breast cancer risk. Cancer Epidemiology, Biomarkers & Prevention. 1998; 7:1133-1144
Kolb et al. Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: An analysis of 27,825 patient evaluations. Radiology. 2002; 225(1):165-175
McCormack, Santos, et al. Breast density and parenchymal pattern as markers of breast cancer risk: A meta-analysis. Cancer Epidemiology, Biomarcers & Prevention. 2006; 15(6):1159-1169
Leung et al. Will screening mammography in the east do more harm than good? American Journal of Public Health. 2002; 92(11):1841-1846
Hammerstein et al. Absorbed radiation dose in mammography. Radiology. 1979; 130:485-491
Brenner DJ, Sawant SG, Hande MP, et al. Routine screening mammography: How important is the radiation-risk side of the benefit-risk equation? International Journal of Radiation Biology. 2002; 78:1065-1067
Heyes GJ, Mill AJ, Charles MW. Enhanced biological effectiveness of low energy X-rays and implications for the UK breast screening programme. The British Journal of Radiology. 2006; 79:195-200
Hoekstra P. Quantitative digital thermology: 21st century imaging systems. In: Paper Presented at: OAND Conference, Hamilton, Ontario. 2001
Son et al. Changing patterns in the clinical characteristics of Korean patients with breast cancer during the last 15 years. Archives of Surgery. 2006; 141(2):155-160
Breast Cancer Risk Factors: A Review of the Evidence. Surry Hills, NSW: National Breast and Ovarian Cancer Centre; 2009
Destounis S, Arieno A, Morgan R, Roberts C, Chan A. Qualitative versus quantitative mammographic breast density assessment: Applications for the US and Abroad. MDPI Diagnostics. 2017
Boyd NF, Byng JW, Jong RA, Fishell EK, Little LE, Miller AB, et al. Quantitative classification of mammographic densities and breast cancer risk: Results from the Canadian National Breast Screening Study. Journal of the National Cancer Institute. 1995; 87(9):670-675
Pike MC, Pearce CL, Wu AH. Prevention of cancers of the breast, endometrium and ovary. Oncogene. 2004; 23:6379-6391 USC/Norris Cancer Center, Los Angeles, CA, USA
Kelemen LE, Pankratz VS, Sellers TA, Brandt KR, Wang A, Janney C, et al. Age-specific trends in mammographic density: The Minnesota breast Cancer family study. American Journal of Epidemiology. 2008; 167:1027-1036
Greendale GA, Reboussin BA, Slone S, Wasilauskas C, Pike MC, Ursin G. Postmenopausal hormone therapy and change in mammographic density. Journal of the National Cancer Institute. 2003; 95:30-37
Maskarinec G, Pagano I, Lurie G, Kolonel LN. A longitudinal investigation of mammographic density: The multiethnic cohort. Cancer Epidemiology, Biomarkers & Prevention. 2006; 15:732-739
McTiernan A, Martin CF, Peck JD, Aragaki AK, Chlebowski RT, Pisano ED, et al. Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women’s Health initiative randomized trial. Journal of the National Cancer Institute. 2005; 97:1366-1376
McCormack VA, dos Santos Silva I. Breast density and parenchymal patterns as markers of breast cancer risk: A meta-analysis. Cancer Epidemiology, Biomarkers & Prevention. 2006; 15(6):1159-1169
Supplemental Screening for Breast Cancer in Women with Dense Breasts: A Systematic Review for the U.S. Preventive Service Task Force. Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services; 2016
Karpov А et al. Diagnostic system in electrical impedance mammography. Background. In: Malik AM, editor. Handbook “New Perspectives in Breast Imaging”. 2018
Ng EYK, Vinitha Sree S, Ng KH, Kaw G. The use of tissue electrical characteristics for breast cancer detection: A perspective review. Technology in Cancer Research and Treatment. August 2008; 7(4):1533-0346
Cure JC. On the electrical characteristics of cancer. In: Paper Presented at the Second International Congress of Electrochemical Treatment of Cancer, Florida. 1995
Revici E. Research in Pathophysiology as Basis for Guided Chemotherapy, with Special Application to Cancer. Princeton, NJ: D. Van Nostrand Company; 1961
Seeger PG, Wolz S. Successful Biological Control of Cancer: By Combat against the Causes. Gesamtherstellung: Neuwieder Verlagsgesellschaft mbH; 1990
Cone CD. The role of surface electrical transmembrane potential in normal and malignant mitogenesis. Annals of the New York Academy of Sciences. 1975; 238:420-435
Cope FW. A medical application of the Ling Association-induction hypothesis: The high potassium, low sodium diet of the Gerson cancer therapy. Physiological Chemistry and Physics. 1978; 10(5):465-468
Cone CD. Transmembrane Potentials and Characteristics of Immune and Tumor Cells. Boca Raton, FL: CRC Press; 1985
Sachin Prasad N, Houserkova D, Campbell J. Breast imaging using 3D electrical impedence tomography. Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czech Republic. 2008; 152(1):151-154
Raneta O, Bella V, Bellova L, Zamecnikova E. The use of electrical impedance tomography to the differential diagnosis of pathological mammographic/sonographic findings. Neoplasma. 2013; 60(6):647-654
Daglar G, Senol K, Yakut ZI, Yuksek YN, Tutuncu T, Tez M, et al. Effectiveness of breast electrical impedance imaging for clinically suspicious breast lesions. Bratislava Medical Journal. 2016; 117(9):505-510
Feng X, Mengxin L, Peter J, Hongchuan J. Utilisation of electrical impedance tomography and/or ultrasound and mammography in breast disease diagnosis: A controlled study. National Medical Journal of China. 2017; 97(18):1391-1395
Murillo-Ortiz B, et al. Diagnosis of breast cancer by electrical impedance mammography MEIK. Revista Mexicana de Mastología. 2019; 9:20-27
Karpov А et al. Electrical impedance mammographic scheme norm and pathology. In: Handbook « Mammoraphy. Techniques and Review». 2015